Skip to Main Content

Author Details

Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
2008
96
37
PMIDPaper TitleJournal TitlePublished Year
38092611Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer.Eur Urol2024
36477467Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.Blood Adv2023
37184881LENS: Landscape of Effective Neoantigens Software.Bioinformatics2023
37083574A multispecies framework for modeling adaptive immunity and immunotherapy in cancer.PLoS Comput Biol2023
37204246Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.J Immunol2023
36882226Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.J Immunother Cancer2023
34088993Sunitinib and Axitinib increase secretion and glycolytic activity of small extracellular vesicles in renal cell carcinoma.Cancer Gene Ther2022
35615349Pharmacological Inhibition of MALT1 Ameliorates Autoimmune Pathogenesis and Can Be Uncoupled From Effects on Regulatory T-Cells.Front Immunol2022
35404674Challenges and Gaps in Clinical Trial Genomic Data Management.JCO Clin Cancer Inform2022
35669345NeoSplice: a bioinformatics method for prediction of splice variant neoantigens.Bioinform Adv2022
35362046Hallmarks of Resistance to Immune-Checkpoint Inhibitors.Cancer Immunol Res2022
36333289Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.Nat Commun2022
36099917Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity.Cell Rep Med2022
35992833Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.Front Oncol2022
36198789STING-induced regulatory B cells compromise NK function in cancer immunity.Nature2022
36351947Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors.NPJ Breast Cancer2022
35044794B Cell Function in the Tumor Microenvironment.Annu Rev Immunol2022
35176136Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.Clin Cancer Res2022
34990404Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition.J Clin Invest2022
33382402STING agonist promotes CAR T cell trafficking and persistence in breast cancer.J Exp Med2021
33882342Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.Transplant Cell Ther2021
33806963Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.Cancers (Basel)2021
33580223Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.Nat Nanotechnol2021
33552976Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases.Front Oncol2021
34994587Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data Challenge.JCO Precis Oncol2021
34474164Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.Transplant Cell Ther2021
34396985Entinostat induces antitumor immune responses through immune editing of tumor neoantigens.J Clin Invest2021
34778801Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Blood Cancer Discov2021
34127050Landscape and selection of vaccine epitopes in SARS-CoV-2.Genome Med2021
33177107Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.Cancer Immunol Res2021
31383567Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.J Autoimmun2020
31696530Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis.J Clin Apher2020
32024640B cell-Derived IL35 Drives STAT3-Dependent CD8[+] T-cell Exclusion in Pancreatic Cancer.Cancer Immunol Res2020
31719055A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor.Cancer Immunol Res2020
32015548Interleukin-23 engineering improves CAR T cell function in solid tumors.Nat Biotechnol2020
31880771Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.Blood2020
31940270The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and Functionality.Immunity2020
33214875CRI iAtlas: an interactive portal for immuno-oncology research.F1000Res2020
33208553Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.JCI Insight2020
33176790Bronchoalveolar Tregs are associated with duration of mechanical ventilation in acute respiratory distress syndrome.J Transl Med2020
32862105Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth.Transl Oncol2020
32627559Alkali Metal Cationization of Tumor-associated Antigen Peptides for Improved Dissociation and Measurement by Differential Ion Mobility-Mass Spectrometry.J Proteome Res2020
32732224Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.Clin Cancer Res2020
32814710CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.JCI Insight2020
32371539Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication.Clin Cancer Res2020
31502156Using RNA Sequencing to Characterize the Tumor Microenvironment.Methods Mol Biol2020
31138334Prognostic value of B cells in cutaneous melanoma.Genome Med2019
31730857B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer.Cell2019
30244102Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant2019
31433971The Immune Landscape of Cancer.Immunity2019
  • 1 - 50 of 96

Recommended Authors

Amrita Basu
University of California San Francisco
Career Start Year 2018
Number of shared co-authors 3
Megan M Richters
Washington University School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Rachel Marty Pyke
University of California San Diego
Career Start Year 2016
Number of shared co-authors 0
Tiago da Silva Medina
International Research Center, A.C.Camargo Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Jihye Park
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 2
Gregory M Chen
University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 1
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 2
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Jasreet Hundal
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 9
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 27
Brandon W Higgs
Translational and Clinical Data Sciences
Career Start Year 2006
Number of shared co-authors 2
Ansuman T Satpathy
Stanford University
Career Start Year 2005
Number of shared co-authors 6
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Jeffrey M Venstrom
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 1
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 31
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 12
Suchit Jhunjhunwala
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 19
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 4
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 10
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 28
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 4

Collaborators

Jonathan S Serody
The University of North Carolina School of Medicine
Co-authored papers 34
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 15
Dante S Bortone
Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill
Co-authored papers 10
Wendy Kimryn Rathmell
Co-authored papers 9
Jeffrey A Frelinger
Co-authored papers 9
Charles M Perou
Co-authored papers 8
Lisa A Carey
Co-authored papers 6
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 6
Lisle E Mose
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 4
Aguirre A de Cubas
Co-authored papers 4
Carey K Anders
Co-authored papers 4
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Hui Shen
Van Andel Institute
Co-authored papers 3
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Co-authored papers 3
David A Wheeler
Baylor College of Medicine
Co-authored papers 3
Justin Guinney
University of Washington
Co-authored papers 3
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 3
Reanne Bowlby
Co-authored papers 3
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 3
David L Gibbs
Institute for Systems Biology
Co-authored papers 3
Vesteinn Thorsson
Institute for Systems Biology
Co-authored papers 3
Thomas J George
UF Health Cancer Center
Co-authored papers 2
Nam Sy Vo
Vingroup Big Data Institute
Co-authored papers 2
Feng Chen
Washington University in St Louis
Co-authored papers 2
James J Hsieh
Washington University
Co-authored papers 2
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 2
William Marston Linehan
Co-authored papers 2
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 2
Release 1.2